Circulating levels of IGF-1- and IGF-binding proteins have been found to be associated with several types of cancers, including colon (Rinaldi et al, 2010), prostate (Roddam et al, 2008), and breast cancer (The Endogenous Hormones and Breast Cancer Collaborative Group, 2010). The gene discussed is IGF1; the disease is breast carcinoma.